Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr (Q45130073)
scientific article published in November 2004
Language:
(P31) (Q13442814)
(P50) (Q41899936)
(Q62569336)
(Q4793409)
(Q97333782)
(Q107318760)
(Q55271466)
(Q115538665)
(Q90696849)
(Q125296758)
(Q114413078)
(P304) 4290-4301
(P407) (Q1860)
(P433) 21
(P478) 22
(P577) Monday, November 1, 2004
(P921) (Q643839)
(Q29496)
(Q180983)
(Q264118)
(Q418817)
(Q411659)
(P1433) (Q400292)
(P1476) "Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr" (language: en)
(P2093) Stephen L George
Richard K Dodge
Steven L Allen
Joseph O Moore
Thomas C Shea
Eva Hoke
other details
description scientific article published in November 2004

External Links